Literature DB >> 15528714

Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.

F Watzinger1, M Suda, S Preuner, R Baumgartinger, K Ebner, L Baskova, H G M Niesters, A Lawitschka, T Lion.   

Abstract

A panel of 23 real-time PCR assays based on TaqMan technology has been developed for the detection and monitoring of 16 different viruses and virus families including human polyomaviruses BK virus and JC virus, human herpesviruses 6, 7, and 8, human adenoviruses, herpes simplex viruses 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, parvovirus B19, influenza A and B viruses, parainfluenza viruses 1 to 3, enteroviruses, and respiratory syncytial virus. The test systems presented have a broad dynamic range and display high sensitivity, reproducibility, and specificity. Moreover, the assays allow precise quantification of viral load in a variety of clinical specimens. The ability to use uniform PCR conditions for all assays permits simultaneous processing and detection of many different viruses, thus economizing the diagnostic work. Our observations based on more than 50,000 assays reveal the potential of the real-time PCR tests to facilitate early diagnosis of infection and to monitor the kinetics of viral proliferation and the response to treatment. We demonstrate that, in immunosuppressed patients with invasive virus infections, surveillance by the assays described may permit detection of increasing viral load several days to weeks prior to the onset of clinical symptoms. In virus infections for which specific treatment is available, the quantitative PCR assays presented provide reliable diagnostic tools for timely initiation of appropriate therapy and for rapid assessment of the efficacy of antiviral treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528714      PMCID: PMC525141          DOI: 10.1128/JCM.42.11.5189-5198.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients.

Authors:  A P Limaye; M L Huang; W Leisenring; L Stensland; L Corey; M Boeckh
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

2.  A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants.

Authors:  A Sirvent-Von Bueltzingsloewen; P Morand; M Buisson; G Souillet; H Chambost; J L Bosson; P Bordigoni
Journal:  Bone Marrow Transplant       Date:  2002-01       Impact factor: 5.483

Review 3.  Clinical utility of viral quantification as a tool for disease monitoring.

Authors:  M Schutten; H G Niesters
Journal:  Expert Rev Mol Diagn       Date:  2001-07       Impact factor: 5.225

Review 4.  Challenges and options in the management of viral infections after stem cell transplantation.

Authors:  Pierre Reusser
Journal:  Support Care Cancer       Date:  2001-09-22       Impact factor: 3.603

5.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

Authors:  A Gustafsson; V Levitsky; J Z Zou; T Frisan; T Dalianis; P Ljungman; O Ringden; J Winiarski; I Ernberg; M G Masucci
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

6.  Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation.

Authors:  H Akiyama; T Kurosu; C Sakashita; T Inoue; K Ohashi; S Tanikawa; H Sakamaki; Y Onozawa; Q Chen; H Zheng; T Kitamura
Journal:  Clin Infect Dis       Date:  2001-04-13       Impact factor: 9.079

7.  Infections after stem cell transplantation in children: state of the art and recommendations.

Authors:  G Dini; E Castagnola; P Comoli; M J van Tol; J M Vossen
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

8.  Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.

Authors:  S D Pas; E Fries; R A De Man; A D Osterhaus; H G Niesters
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Enteroviral meningoencephalitis in immunocompromised children after matched unrelated donor-bone marrow transplantation.

Authors:  G Fischmeister; P Wiesbauer; H M Holzmann; C Peters; M Eibl; H Gadner
Journal:  Pediatr Hematol Oncol       Date:  2000 Jul-Aug       Impact factor: 1.969

Review 10.  Automation of laboratory testing for infectious diseases using the polymerase chain reaction-- our past, our present, our future.

Authors:  D Jungkind
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

View more
  99 in total

Review 1.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Malin I L Sjöholm; Joakim Dillner; Joyce Carlson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

3.  Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.

Authors:  Peter A C Maple; Lea Hedman; Pravesh Dhanilall; Kalle Kantola; Visa Nurmi; Maria Söderlund-Venermo; Kevin E Brown; Klaus Hedman
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

4.  Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples.

Authors:  Justine Cheval; Virginie Sauvage; Lionel Frangeul; Laurent Dacheux; Ghislaine Guigon; Nicolas Dumey; Kevin Pariente; Claudine Rousseaux; Fabien Dorange; Nicolas Berthet; Sylvain Brisse; Ivan Moszer; Hervé Bourhy; Claude Jean Manuguerra; Marc Lecuit; Ana Burguiere; Valérie Caro; Marc Eloit
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

5.  Optimization of qRT-PCR assay for zika virus detection in human serum and urine.

Authors:  Maria Del Pilar Martinez Viedma; Vinita Puri; Lauren M Oldfield; Reed S Shabman; Gene S Tan; Brett E Pickett
Journal:  Virus Res       Date:  2019-02-10       Impact factor: 3.303

6.  Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.

Authors:  Luke A Wiley; Erin R Burnight; Arlene V Drack; Bailey B Banach; Dalyz Ochoa; Cathryn M Cranston; Robert A Madumba; Jade S East; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Hum Gene Ther       Date:  2016-07-11       Impact factor: 5.695

7.  Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR.

Authors:  Karin Ebner; Margit Rauch; Sandra Preuner; Thomas Lion
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

8.  Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

Authors:  Maria A Thomas; Jacqueline F Spencer; Karoly Toth; John E Sagartz; Nancy J Phillips; William S M Wold
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

9.  Impact of human bocavirus on children and their families.

Authors:  Susanna Esposito; Samantha Bosis; Hubert G M Niesters; Elena Tremolati; Caterina Sabatini; Alessandro Porta; Emilio Fossali; Albert D M E Osterhaus; Nicola Principi
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

10.  Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.

Authors:  Rachele Ciccocioppo; Francesca Racca; Luigia Scudeller; Antonio Piralla; Pietro Formagnana; Lodovica Pozzi; Elena Betti; Alessandro Vanoli; Roberta Riboni; Peter Kruzliak; Fausto Baldanti; Gino Roberto Corazza
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.